After safety review The Connection study is now again open to recruit the smallest infants.
After safety review The Connection study is now again open to recruit the smallest infants. Following the completion of the…
Pharmaceuticals, Biotechnology and Life Sciences
After safety review The Connection study is now again open to recruit the smallest infants. Following the completion of the…
– Data from subjects with available dual energy x-ray absorptiometry (DXA) scans demonstrated stabilization of BMD, in alignment with observed…
YARDLEY, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose…
CAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…
– Cantor Fitzgerald Virtual Global Healthcare Conference: September 30 – – The Cell & Gene Meeting on the Mesa Annual Conference:…
Continuous glucose monitoring reveals undertreated hypoglycemia in patients with congenital hyperinsulinism RZ358, a monoclonal antibody in Phase 2b development, has…
ELI-005, containing the Amphiphile vaccine adjuvant AMP-CpG, induced >25-fold higher antigen-specific T cells in the peripheral blood and exhibited potent…
Nine Towers Completed with a value of $620,000VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP.…
ERYTECH Announces the Availabilityof its Half-Year Financial Report 2021 Lyon (France) and Cambridge, MA (U.S.), Septembre 22, 2021 – ERYTECH…
PRESS RELEASE AB SCIENCE RECEIVES HEALTH CANADA APPROVAL LETTER TO COMMENCE PHASE I/II TRIAL OF AB8939 IN THE TREATMENT OF…